Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative, Multicenter Study Estimating Association Between Germline DNA-repair Genes Mutations and PD-L1 Expression Level in Breast Cancer

NCT03495544 is registered in ClinicalTrials.gov with Tatarstan Cancer Center as lead sponsor.

NCT NCT03495544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03495544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative, Multicenter Study Estimating Association Between Germline DNA-repair Genes Mutations and PD-L1 Expression Level in Breast Cancer
Lead sponsor
Tatarstan Cancer Center
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
July 1, 2019
Enrollment
390 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary breast cancer